Key Series Technology
The technology used in the Key Devices relies on the body’s mechanism of adaptation, ensuring dynamic equilibrium or, homeostasis. Regulation of the body’s vital functions is achieved through close connection and interaction of the nervous and endocrine systems. The effects of these systems results in the release of biologically active chemical modulators called neuromediators. Examples of these are acetylcholine, adrenaline and nor-adrenaline. Amino acids are another type of chemical modulator. These are important in activation of the thickly myelinated A- and B-neural fibres. Examples of this modulator include glutamine and asparagine. The largest group of chemical modulators are the neuromediators and include endorphins (the ‘feel good’ chemical modulator), enkephalins and bradykinin.
Central to massage therapy with the Key devices, are the body’s chemical modulators, neuropeptides. These are the main modulators of neural activity of the thin non-myelinated, ‘difficult-to-excite’ C-fibres. These neuropeptide-producing nerve fibres make up more than 70% of the body’s neural tracts. C-fibre’s specific properties enable the production of a powerful analgesic effect, which is brought about by the release of neuropeptides, once the C-fibre is activated.
The main goal of Key device massage therapy is fast and sustained pain relief by activating a maximum number of C-fibres to induce the secretion of a sufficient amount of neuropeptides.
The bio-feedback controlled massage impulse of the Key devices means that the device communicates actively with the processes that are happening in the body by monitoring the skin’s impedance and then adjusts the massage impulse it is sending out in accordance with the changes in the skin’s impedance.
The characteristics of the bio-feedback controlled massage impulses are such that the probability of excitation of the thin neuropeptide-secreting C-fibres is higher than conventional methods of electrotherapy ₉ ₁₀ ₁₁.
Clinical experience with the technology has further indicated that the optimal therapeutic effect is achieved when there is a maximal variability of the impulse parameters during treatment ₁₂ ₁₃ ₁₄.
The optimum therapeutic results are always dependent upon the patient’s body’s response and therefore individual to each client. As the device monitors and evaluates treatment results it independently delivers the correct massage impulse without the possibility of overdosing and hence very few side effects.
9. Somers D, Clemente F R, TENS for the management of neuropathic pain: The effects of frequency and electrode position on prevention of allodynia in a rat model of CRPS type II, Phys Ther, Vol. 86, no.5, 2006: pg 698-709
10. Han J S, Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends in Neurosciences, Vol. 26, No.1, January 2003
11. Hamza, M.A. et al. (1999) Effect of the frequency of transcutaneous electrical nerve stimulation on the postoperative opioid analgesic requirement and recovery profile. Anesthesiology 91, 1232–1238
12. Melzack R: Prolonged relief of pain by brief, intense transcutaneous somatic stimulation. Pain. 1975;1: 357-373.
13. Chandran P, Sluka KA. Development of opioid tolerance with repeated transcutaneous electrical nerve stimulation administration. Pain. 2003;102:195–201
14. Josimari M. DeSantana, PhD, Valter J. Santana-Filho, MSc, Kathleen A. Sluka, PhD: Modulation Between High- and Low-Frequency Transcutaneous Electric Nerve Stimulation Delays the Development of Analgesic Tolerance in Arthritic Rats Arch Phys Med Rehabil Vol 89, April 2008: pg 754-760
Key Health Technology
free call: 1855 972 3627